Charles Schwab Investment Management Inc Royalty Pharma PLC Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 3,001,603 shares of RPRX stock, worth $75.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,001,603
Previous 1,898,262
58.12%
Holding current value
$75.6 Million
Previous $50.1 Million
69.64%
% of portfolio
0.02%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding RPRX
# of Institutions
414Shares Held
283MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.04 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$947 Million0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$580 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$406 Million0.35% of portfolio
-
Viking Global Investors LP12.1MShares$305 Million1.32% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...